Prestige Biopharma Receives 2022 Asia-Pacific Bioprocessing Excellence Awards

来源: 编辑: 发布: 2022-04-02 11:46

SINGAPORE--(BUSINESS WIRE)--Prestige Biopharma Limited a Singapore-based leading biopharmaceutical with operations in USA and South Korea, announced that the company has been recognized as the grand winner of the Bioprocessing Excellence in SEA (South-East Asia).

The Awards Ceremony was held in conjunction with the 9th Biologics Manufacturing Asia and 6th Biologistics World Asia 2022 hybrid Conference, which was streamed live on 29 - 30 March 2022.

Asia Pacific Bioprocessing Excellence Awards recognizes exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality. The panel of expert judges include key opinion leaders with more than 20 years of experience from all the key players in Asia and globally.

“We are very proud to receive this award and thank you for recognizing Prestige’s passion for driving innovation and change in bioprocessing,” said Dr. Deborah Moshinsky, Head of Global R&D of Prestige in her acceptance speech. “Prestige Group has undergone a significant expansion to our manufacturing capabilities. Our EU-GMP certified facility with global compliance recognition is currently expanding its capacity up to 234,000 liters through its 2nd Campus developments.”

Prestige has developed biosimilars and first-in-class antibody drugs of high quality and strong cost competitiveness in expedited development programmes, with its proprietary bioprocessing technology.

Prestige’s leading pipeline HD201 trastuzumab (Tuzune®) is currently under EU EMA’s MAA review and its manufacturing facility, Prestige Biologics, has received European Union Good Manufacturing Practices (GMP) certification last February.

The company’s robust pipeline in clinical stage also includes an innovative therapy for pancreatic cancer, PBP1510 (INN: Ulenistamab) in Phase 1/2a clinical trial in Europe, an Avastin biosimilar HD204 (Vasforda®) in global Phase 3, and a Humira biosimilar PBP1502 in Phase 1 clinical trial in Europe.

猜你还想看:

本网网友:余命72 G3nTL3m
评论:好的文字是这样的:你写得不动声色,我看得肝肠寸断

网易网友:识趣 Content つ
评论:世界上没有绝对幸福圆满的婚姻,幸福只是来自于无限的容忍与互相尊重。

搜狐网友:爱情° love
评论:每次听到有人在吆喝回收废品我就想到把你卖了。

猫扑网友:Curtain情歌
评论:我的兴趣爱好可分为静态和动态两种,静态就是睡觉,动态就是翻身

天涯网友:゛风骚, - /ov3
评论:世界上最远的距离不是生与死,而是我在新浪微博,而你却在腾讯微博。

淘宝网友:不相离°  1/m*
评论:命是爸妈给的,珍惜点;路是自己走的,小心点。

腾讯网友:你就如此不堪
评论:我来到我们来过的小路,捡起我们可耻的幸福。

百度网友:㎜  安然失笑
评论:学习伤我千千遍,我待学习如初恋。

凤凰网友:寻找爱 Looking
评论:吃货都是善良的,因为每天只想着吃,没时间去算计别人

其它网友:memory’流年
评论:感情之所以惨淡,是通常一个人乞求,另一个人却不施舍